期刊文献+

MR波谱脂峰对前列腺中央腺体谱线的影响 被引量:1

Study on the influence of lipid peak to the results of MR spectroscopy in the centraI gland of prostate
原文传递
导出
摘要 目的探讨 MR 波谱(MRS)中脂峰对前列腺中央腺体谱线的影响。方法对17例因良性前列腺增生(BPH)行经尿道前列腺切除术(TURP)患者的 MRS 谱线作回顾性分析,根据病理结果分为3组:中央腺体偶发癌(IDPC)组4例、腺体增生为主的 BPH(glandular BPH,GBPH)组7例,基质增生为主的 BPH(stromal BPH,SBPH)组6例。统计中央腺体感兴趣区内出现脂峰的体素,并与病理结果对照,分析脂峰在中央腺体出现的常见位置及对 MRS 谱线识别产生的干扰。结果位于中央腺体的 MRS 体素共3567个,有脂峰体素834个,占中央腺体总体素的22.8%。其中,GBPH、SBPH 和IDPC 组测量的体素数分别为1477、1434和656个,有脂峰体素分别为397、396和41个。上述3组患者有脂峰体素所占比率的中位数分别为23.6%、27.2%和6.4%。有脂峰体素多位于中央腺体的边缘,3组所占比率的中位数分别为79.6%、68.6%和72.4%。脂峰多不会对谱线识别造成干扰,3组所占比率中位数分别为82.8%、98.0%和96.4%。结论前列腺中央腺体的 MRS 谱线中,脂峰可能与腺体周围脂肪组织有关,而且大多数未影响到谱线的识别。 Objective To study the influence of lipid peak to MRS in central gland of prostate gland. Methods Seventeen patients performed transurethral resection of prostate (TURP) for benign prostate hyperplasia (BPH) were enrolled in this study. Three groups were divided according to the pathological findings : glandular-BPH ( GBPH ) ( 7 cases ), stromal-BPH ( SBPH ) ( 6 cases ), and incidentally detected prostate carcinoma (IDPC) (4 cases). The voxel with lipid peak in the field of volume was counted. Compared with pathology, the following studies were performed : ( 1 ) The location of the voxels that more frequently presented lipid peak in the central gland. (2) Whether the appearance of the lipid peak would obscure the identification of the peaks of the endogenous metabolites. Results The ratio of voxels with lipid peak in central gland was about 22. 8% ( 834/3567 ). There were 1477 ( 397 voxels with lipid peak) , 1434(396 voxels with lipid peak) , and 656(41 voxels with lipid peak) voxels in GBPH, SBPH, and IDPC groups, respectively. The percentage in GBPH, SBPH, and IDPC groups was 23.6% , 27.2% , and 6.4% , respectively. The percentage of voxels with lipid peak at the edge of the central gland (79.6% , 68.6% and 72.4% , respectively ) was higher than that in other regions. The lipid peak in most of the voxels didn't influence the identification of the citrate and choline peak (82. 8% , 98. 0%, and 96. 4%, respectively). Conclusion The lipid peak in the central gland may result from the lipid tissues near the gland, and most lipid peak had no influence on the identification of endogenous metabolites.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2007年第12期1390-1393,共4页 Chinese Journal of Radiology
关键词 前列腺增生 前列腺肿瘤 磁共振波谱学 Prostatic hyperplasia Prostatic neoplasms Magnetic resonance spectroscopy
  • 相关文献

参考文献10

  • 1周良平,王霄英,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.正常前列腺、前列腺癌和良性前列腺增生的MR波谱成像代谢特征并与病理结果对照[J].中华放射学杂志,2005,39(1):50-53. 被引量:34
  • 2Bovee WM, Keevil SF, Leach MO, et al. Quality assessment in vivo NMR spectroscopy: Ⅱ,a protocol for quality assessment:EEC Concerted Research Project. Magn Reson Imaging, 1995, 13: 123-129.
  • 3Kaji Y, Kurhanewicz J, Hricak H, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology, 1998, 206: 785 -790.
  • 4Kurhanewicz J, Vigneron DB, Hricak H, et al. Three- dimensional H-1 MR imaging of the in situ human prostate with high( 0. 24-0. 7 cm^3 ) spatial resolution. Radiology, 1996, 198 : 795 -805.
  • 5Zakian KL, Eberhardt S, Hricak H, et al, Transition zone prostate cancer: metabolic characteristics at ^1H MR spectroscopic imaging-initial results. Radiology,2003,229:241-247.
  • 6李飞宇,王霄英,丁建平,周良平,黄嵘,蒋学祥.中国男性良性前列腺增生的MR波谱定量分析[J].中华放射学杂志,2005,39(4):390-393. 被引量:18
  • 7Lowry M, Liney GP, Tumbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences. Magn Reson Med, 1996,36: 352-358.
  • 8Ackerstaff E, Ptlug BR, Nelson SJ, et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent transformation of prostatic epithelial cells. Cancer Research,2001,61:3599-3603.
  • 9王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 10Liney GP, Turnbull LW, Lowry M, et al. In vivio quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using ^1H MRS and MRI. Magn Reson Imaging, 1997,15 : 1177 - 1186.

二级参考文献23

  • 1王霄英,周良平,丁建平,王刚,肖江喜,蒋学祥.中国正常成年男性前列腺的MRS定量分析[J].中国医学影像技术,2003,19(5):576-578. 被引量:24
  • 2[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 3[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 4[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 5[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 6[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 7[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 8[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 9[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.
  • 10Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24-0.7 cm3) spatial resolution. Radiology, 1996, 198: 795-805.

共引文献122

同被引文献13

  • 1王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 2周良平,王霄英,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.正常前列腺、前列腺癌和良性前列腺增生的MR波谱成像代谢特征并与病理结果对照[J].中华放射学杂志,2005,39(1):50-53. 被引量:34
  • 3Kurhanewicz J,Vigneron DB,Hricak H,et al.Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24-0.7cm3)spatial resolution[J].Radiology,1996,198(3):795-805.
  • 4Zakian KL,Eberhardt S,Hricak H,et al.Transition zone prostate cancer:metabolic characteristics at 1H MR spectroscopic imaging initial results[J].Radiology,2003,229(1):241-247.
  • 5Shukla DA,Hricak H,Eberhardt SC,et al.Chronic prostatitis:MR imaging and 1 H MR spectroscopic imaging findings initial observations[J].Radiology,2004,231(3):717-724.
  • 6Ackerstaff E,Pflug BR,Nelson SJ,et al.Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent transformation of prostatic epithlial cells[J].Cancer Res,2001,61(9):3599-3603.
  • 7Rajesh A,Coakley FV,Kurhanewicz J.3D MR spectroscopic imaging in the evaluation of prostate cancer[J].Clin Radiol,2007,62(10):921-929.
  • 8Lowry M,Liney GP,Tumbull LW,et al.Quantification of citrate concentration in the prostate by proton magnetic spectroscopy:zonal and age-related differences[J].Magn Reson Med,1996,36(3):252-358.
  • 9GarCia-Segura JM,Sanchez-Chapado M,Ibarburen C,et al.In vivo proton magnetic resonance spectroscopy of diseased prostate:spectroscopic features of malignant versus benign pathology[J].Magn Reson Imaging,1999,17(5):755-765.
  • 10李飞宇,王霄英,肖江喜,蒋学祥.前列腺癌质子MR波谱诊断标准的研究进展[J].中华放射学杂志,2007,41(9):989-991. 被引量:4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部